Philippe Deguiral

485 total citations
17 papers, 246 citations indexed

About

Philippe Deguiral is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Philippe Deguiral has authored 17 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Philippe Deguiral's work include Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Treatment and Pharmacology (6 papers). Philippe Deguiral is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Treatment and Pharmacology (6 papers). Philippe Deguiral collaborates with scholars based in France, India and Belgium. Philippe Deguiral's co-authors include É. Bardet, Jean-Yves Douillard, Jaafar Bennouna, Olivier Bouché, Laurent Bedenne, Harry Bleiberg, B. Gérard, François‐Régis Ferrand, Bernard Leduc and Samy Louafi and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Philippe Deguiral

17 papers receiving 238 citations

Peers

Philippe Deguiral
Els Monsaert Belgium
Michael A. Choti United States
Giovanna Sabella Italy
Mustafa Karaağaç Türkiye
Martine Blazquez France
Lauren M. Postlewait United States
Filippo Pagani Italy
Hajime Ushigome Japan
N. C. Tebbutt Australia
Stefano Marcucci Italy
Els Monsaert Belgium
Philippe Deguiral
Citations per year, relative to Philippe Deguiral Philippe Deguiral (= 1×) peers Els Monsaert

Countries citing papers authored by Philippe Deguiral

Since Specialization
Citations

This map shows the geographic impact of Philippe Deguiral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Deguiral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Deguiral more than expected).

Fields of papers citing papers by Philippe Deguiral

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Deguiral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Deguiral. The network helps show where Philippe Deguiral may publish in the future.

Co-authorship network of co-authors of Philippe Deguiral

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Deguiral. A scholar is included among the top collaborators of Philippe Deguiral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Deguiral. Philippe Deguiral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Beaussire, Ludivine, Sylvain Manfrédi, Karine Le Malicot, et al.. (2022). Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer. Frontiers in Oncology. 12. 973167–973167. 10 indexed citations
2.
Lepage, Côme, Jean–Marc Phelip, Laurent Cany, et al.. (2020). 398O Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial. Annals of Oncology. 31. S410–S410. 5 indexed citations
3.
Lepage, Côme, Jean–Marc Phelip, Laurent Cany, et al.. (2015). Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial. Digestive and Liver Disease. 47(7). 529–531. 28 indexed citations
4.
Martin-Babau, J., Jean‐Yves Douillard, Olivier Dupuis, et al.. (2015). Is panitumumab monotherapy safe in metastatic colorectal cancer patients over 70 years old?. Journal of Clinical Oncology. 33(3_suppl). 714–714. 1 indexed citations
5.
Metges, Jean Philippe, Jean‐Yves Douillard, Éveline Boucher, et al.. (2014). Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer.. Journal of Clinical Oncology. 32(3_suppl). 305–305. 12 indexed citations
6.
Metges, Jean‐Philippe, Roger Faroux, Jean‐Yves Douillard, et al.. (2014). FOLFIRINOX in first-line metastatic pancreatic cancer regimen (FLMPC): What profile of patients take a real advantage? Real world cohort from cancer observatory from Brittany and Pays de la Loire areas.. Journal of Clinical Oncology. 32(15_suppl). e15204–e15204. 1 indexed citations
7.
Metges, Jean‐Philippe, Roger Faroux, Jean-Yves Douillard, et al.. (2013). Efficacy and safety of FOLFIRINOX in patients with pancreatic metastatic cancer.. Journal of Clinical Oncology. 31(4_suppl). 248–248. 1 indexed citations
8.
9.
Dupuis, Olivier, Véronique Guerin‐Meyer, M. Porneuf, et al.. (2012). Panitumumab as a single agent in 269 metastatic colorectal cancer patients in the real practice: A post EMA approval study.. Journal of Clinical Oncology. 30(15_suppl). e14148–e14148. 1 indexed citations
10.
Douillard, Jean‐Yves, Olivier Dupuis, Véronique Guerin‐Meyer, et al.. (2012). Efficacity and safety of panitumumab in mCRC patients: A post-AMM OMIT study.. Journal of Clinical Oncology. 30(4_suppl). 608–608. 1 indexed citations
11.
Metges, J-P., Jean‐François Ramée, Olivier Dupuis, et al.. (2012). Panerb Study: Which Category of Patients, Suffering from Metastatic Colorectal Cancer, Can Benefit From Panitumumab Treatment After Cetuximab-Based Regimen Failure?. Annals of Oncology. 23. ix196–ix196. 2 indexed citations
12.
Campone, Mario, Jean‐Sébastien Frenel, Priscilla Soulié, et al.. (2011). Bevacizumab and irinotecan in patients with recurrent glioblastoma (GBM): Results of a retrospective cohort study of the OMIT Bretagne and Pays de la Loire.. Journal of Clinical Oncology. 29(15_suppl). 2086–2086. 2 indexed citations
13.
Bennouna, Jaafar, É. Bardet, Philippe Deguiral, & Jean-Yves Douillard. (2000). Small Cell Carcinoma of the Esophagus. American Journal of Clinical Oncology. 23(5). 455–459. 71 indexed citations
14.
15.
Agard, C., et al.. (1998). Une tumeur neuroendocrine métastatique d'évolution exceptionnelle!. La Revue de Médecine Interne. 19(6). 438–441. 3 indexed citations
16.
Bourin, Michel, Martine Hascoët, & Philippe Deguiral. (1996). 5‐HTP induced diarrhea as a carcinoid syndrome model in mice?. Fundamental and Clinical Pharmacology. 10(5). 450–457. 11 indexed citations
17.
Bleiberg, Harry, B. Gérard, & Philippe Deguiral. (1992). Adjuvant therapy in resectable gastric cancer. British Journal of Cancer. 66(6). 987–991. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Els Monsaert Breakdown of academic impact, for papers by Michael A. Choti Breakdown of academic impact, for papers by Giovanna Sabella Breakdown of academic impact, for papers by Mustafa Karaağaç Breakdown of academic impact, for papers by Martine Blazquez Breakdown of academic impact, for papers by Lauren M. Postlewait Breakdown of academic impact, for papers by Filippo Pagani Breakdown of academic impact, for papers by Hajime Ushigome Breakdown of academic impact, for papers by N. C. Tebbutt Breakdown of academic impact, for papers by Stefano Marcucci
Rankless by CCL
2026